The conundrum of chronic kidney disease classification and end-stage renal risk prediction in the elderly-what is the right approach?

Nephron - Clinical Practice

Volumn 116, Issue 4, 2010, Pages

  Hallan, Stein Ivar ^a,b   Orth, Stephan Reinhold ^c,d  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c Dialysis Centre Bad Aibling   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Albumin excretion; Chronic kidney disease classification; Elderly; End stage renal disease; Risk

Indexed keywords

AGED; AGING; ALBUMINURIA; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INFLAMMATION; JAPAN; KIDNEY FAILURE; MORTALITY; NORWAY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; SHORT SURVEY; TAIWAN; UNITED KINGDOM; UNITED STATES;

AGE FACTORS; AGED; ANIMALS; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 77954869012     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319166     Document Type: Short Survey

References (56)

1. Coresh J, Selvin E, Stevens LA, et al: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047. (Pubitemid 350074801)
2. Hallan SI, Coresh J, Astor BC, et al: International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17:2275-2284.
3. Zhang L, Zhang P, Wang F, et al: Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008; 51: 373-384.
4. U.S. Renal Data System: USRDS Annual Data Reports (2000-2009): Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, 2010. http://www.usrds. org/adr.htm (accessed March 22 2010).
5. Coresh J, Stevens LA, Levey AS: Chronic kidney disease is common: what do we do next? Nephrol Dial Transplant 2008; 23: 1122-1125.
6. Eknoyan G: Chronic kidney disease definition and classification: no need for a rush to judgment. Kidney Int 2009; 75: 1015-1018.
7. Glassock RJ, Winearls C: Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol 2008; 3:1563-1568.
8. Glassock RJ, Winearls C: CKD-fiction not fact. Nephrol Dial Transplant 2008; 23: 2695-2696.
9. Glassock RJ, Winearls CG: eGFR: Readjusting its rating. Clin J Am Soc Nephrol 2009; 4: 867-869.
10. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39(suppl 2):1-246.
11. Chadban SJ, Briganti EM, Kerr PG, et al: Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003; 14(7 suppl 2):S131-S138.
12. Clase CM, Garg AX, Kiberd BA: Prevalence of low glomerular filtration rate in nondia-betic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2002; 13: 1338-1349.
13. Coresh J, Astor BC, McQuillan G, et al: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39:920-929.
14. Hallan S, Astor BC, Lydersen S: Estimating glomerular filtration rate in the general population: the second Health Survey of Nord Trondelag (HUNT II). Nephrol Dial Transplant 2006; 21:1525-1533.
15. Levey AS, Stevens LA, Schmid CH, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
16. Glassock RJ, Winearls C: An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 2008; 23: 1117-1121.
17. Glassock RJ, Winearls C: Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol 2008; 3:1563-1568.
18. Getz L, Kirkengen AL, Hetlevik I, Romund-stad S, Sigurdsson JA: Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice. A descriptive epide-miological study. Scand J Prim Health Care 2004; 22: 202-208.
19. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 2002; 61:2165-2175.
20. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG: The aging kidney. Kidney Int 2008; 74: 710-720.
21. Davies DF, Shock NW: Age changes in glo-merular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29:496-507.
22. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P: Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005; 16: 763-773.
23. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW: The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976; 31:155-163.
24. Fliser D, Zeier M, Nowack R, Ritz E: Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol 1993; 3:1371-1377.
25. Wang M, Monticone RE, Lakatta EG: Arterial aging: a journey into subclinical arterial disease. Curr Opin Nephrol Hypertens 2010; 19: 201-207.
26. Hermans MM, Henry R, Dekker JM, et al: Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol 2007; 18: 1942-1952.
27. Peralta CA, Katz R, Madero M, et al: The differential association of kidney dysfunction with small and large arterial elasticity: the multiethnic study of atherosclerosis. Am J Epidemiol 2009; 169:740-748.
28. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C: Screening for chronic kidney disease: where does Europe go? Clin J Am Soc Nephrol 2008; 3:616-623.
29. Yamamoto S, Kon V: Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Curr Opin Nephrol Hy-pertens 2009; 18: 181-188.
30. Moranne O, Froissart M, Rossert J, et al: Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 2009; 20: 164-171.
31. Lewington S, Clarke R, Qizilbash N, et al: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
32. Harris T, Feldman JJ, Kleinman JC, Ettinger WH, Makuc DM, Schatzkin AG: The low cholesterol-mortality association in a national cohor t. J Clin Epidemiol 1992; 45: 595-601.
33. Vischer UM, Safar ME, Safar H, et al: Car-diometabolic determinants of mortality in a geriatric population: is there a 'reverse metabolic sy ndrome'? Diabetes Metab 2009; 35: 108-114.
34. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990; 300:297-300.
35. Perkovic V, Verdon C, Ninomiya T, et al: T he relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med 2008; 5:e207.
36. Astor BC, Hallan SI, Miller ER III, Yeung E, Coresh J: Glomerular filtration rate, albu-minuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008; 16 7: 1226-1234.
37. de Boer IH, Katz R, Cao JJ, et al: Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care 2009; 32: 1833-1838.
38. Farbom P, Wahlstrand B, Almgren P, et al: Interaction between renal function and mi-croalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study. Hypertension 2008; 52:115-122.
39. Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, Coresh J: Associat ion of k id ney function and albuminuria with cardiovascular mortality in older versus younger individuals: the HUNT II study. Arch Intern Med 2007; 16 7: 2490-2496.
40. Ninomiya T, Perkovic V, de Galan BE, et al: Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009; 20:1813-1821.
41. Vlek AL, van der Graaf Y, Spiering W, Algra A, Visseren FL, SMART Study Group: Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease. J Intern Med 2008; 264: 351-360.
42. Mancia G, De Backer G, Dominiczak A, et al: 2007 Guidelines for the management of arterial hypertension: The Task Force for the Ma nagement of Arter ia l Hy per tension of t he European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
43. Taal MW, Brenner BM: Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int 2006; 70: 1694-1705.
44. Hallan SI, Dahl K, Oien CM, et al: Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333:1047.
45. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164:659-663.
46. Ikizler TA: CKD classification: time to move beyond KDOQI. J Am Soc Nephrol 2009; 20: 929-930.
47. Iseki K, Kinjo K, Iseki C, Takishita S: Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004; 4 4: 806-814.
48. Ishani A, Grandits GA, Grimm RH, et al: Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 2006; 17:1444-1452.
49. Keane WF, Zhang Z, Lyle PA, et al: Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL Study. Clin J Am Soc Nephrol 2006; 1:761-767.
50. Lea J, Greene T, Hebert L, et al: The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med 2005; 165:947-953.
51. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR: Combining GFR and al-buminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009; 20: 1069-1077.
52. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P: Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159:882-890.
53. Roderick PJ, Atkins RJ, Smeeth L, et al: CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 2009; 53: 950-960.
54. Kagiyama S, Matsumura K, Ansai T, et al: Chronic kidney disease increases cardiovascular mortality in 80-year-old subjects in Japan. Hypertens Res 2008; 31:2053-2058.
55. Rifkin DE, Katz R, Chonchol M, et al: Albu-minuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant 2010; 25: 1560-1567.
56. Hwang SJ, Lin MY, Chen HC, et al: Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan. Nephrol Dial Transplant 2008; 23: 3192-3198.